Edition:
India

People: Anavex Life Sciences Corp (AVXL.OQ)

AVXL.OQ on NASDAQ Stock Exchange Capital Market

2.48USD
15 Nov 2019
Change (% chg)

$0.08 (+3.33%)
Prev Close
$2.40
Open
$2.45
Day's High
$2.49
Day's Low
$2.42
Volume
83,592
Avg. Vol
81,059
52-wk High
$4.08
52-wk Low
$1.25

Skarpelos, Athanasios 

Mr. Athanasios Skarpelos is an Independent Director of Anavex Life Sciences Corp., effective January 9, 2013. Mr. Skarpelos self-employed investor with 18 years of experience working with private and public companies. For the past 10 years, he has been focused on biotechnology companies involved in drug discovery and drug development projects. Mr. Skarpelos was engaged as a consultant to our company for one year effective August 2, 2010. His experience has led to relationships with researchers at academic institutes in Europe and North America. Mr. Skarpelos is a founder of Anavex.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --